Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 29141948

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2018 Jan 25
First author
Amengual JE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2018 Jan 25;131(4):375-376. doi: 10.1182/blood-2017-11-817734.
    note
    Source null
    related pmid
    29371206
    relationship
    Comment in

Authors and identifiers

  1. name
    Amengual JE
    type
    Author
  2. name
    Lichtenstein R
    type
    Author
  3. name
    Lue J
    type
    Author
  4. name
    Sawas A
    type
    Author
  5. name
    Deng C
    type
    Author
  6. name
    Lichtenstein E
    type
    Author
  7. name
    Khan K
    type
    Author
  8. name
    Atkins L
    type
    Author
  9. name
    Rada A
    type
    Author
  10. name
    Kim HA
    type
    Author
  11. name
    Chiuzan C
    type
    Author
  12. name
    Kalac M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Amengual JE
    type
    Author
  2. name
    Lichtenstein R
    type
    Author
  3. name
    Lue J
    type
    Author
  4. name
    Sawas A
    type
    Author
  5. name
    Deng C
    type
    Author
  6. name
    Lichtenstein E
    type
    Author
  7. name
    Khan K
    type
    Author
  8. name
    Atkins L
    type
    Author
  9. name
    Rada A
    type
    Author
  10. name
    Kim HA
    type
    Author
  11. name
    Chiuzan C
    type
    Author
  12. name
    Kalac M
    type
    Author
bibliography ids
  1. nci-bib-a6003877a0322e9b1a89edf8
book metadata
content sha256
dc4ab4e650f7ce6caba382e7d8e095a2a600c27df4c2a2112e1fc31a91dd8b95
document type
citation
dois
  1. 10.1182/blood-2017-09-806737
electronic publication date
display
2017 Nov 15
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29141948
immutable id
pubmed:29141948@dc4ab4e650f7ce6caba382e7d8e095a2a600c27df4c2a2112e1fc31a91dd8b95
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
4
name
Blood
nlm unique id
7603509
pages
397-407
volume
131
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2018 Jan 25;131(4):375-376. doi: 10.1182/blood-2017-11-817734.
    note
    Source null
    related pmid
    29371206
    relationship
    Comment in
outcomes validated
false
pmid
29141948
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
79759c0206764526ff6ab521ade24d8e78c95bb0a4e6c54b55875cd0221321c5
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2018 Jan 25
precision
day
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29141948/
title
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice